Recent Company News

• 12:12 PM ET Apr 28, 2025
  

  Adocia will present new data on AdoShell at scientific conferences, highlighting its potential as a curative treatment for type 1 diabetes (€4.00, 0.00)

• 12:06 PM ET Apr 17, 2025
  

  Adocia reports FY net income (€9.3M) vs year-ago (€21.2M) (€3.85, 0.00)

• 05:55 AM ET Apr 04, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (337 total)

• 04:45 AM ET Apr 03, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (255 total)

• 05:34 AM ET Mar 28, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (112 total)

• 04:58 AM ET Mar 26, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (128 total)

• 02:45 AM ET Feb 26, 2025
  

  Adocia successful completion of a €9.7M private placement, extending its cash runway to Q2 of 2026 (€4.73, 0.00)

• 01:06 PM ET Feb 25, 2025
  

  Adocia reports Q4 revenue €9.3M vs year-ago €0.2M (€4.73, 0.00)

• 03:52 AM ET Feb 19, 2025
  

  StreetAccount Summary: EU stocks reaching new 52-week highs/lows (134 total)

• 03:58 AM ET Dec 13, 2024
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning